We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Xanthine Oxidase Inhibition in Renal Transplant Recipients (XART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01332799
Recruitment Status : Active, not recruiting
First Posted : April 11, 2011
Last Update Posted : March 28, 2017
Information provided by (Responsible Party):
Roberto S Kalil, University of Iowa

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2018
  Estimated Study Completion Date : March 2018